European Journal of Clinical Investigation Overview
The European Journal of Clinical Investigation (EJCI), in publication since 1970, is a peer-reviewed general-interest biomedical journal with a broad readership. It is the official journal of the European Society for Clinical Investigation (ESCI).
Aims and Scope
EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.
Readership
Interpreting clinical investigation, the journal widely covers all aspects of this multidisciplinary field. The editorial board reflects the broad approach of the journal. The readership covers all specialities within this area of research and is predominantly read by physicians and laboratory research workers. Received by all members of ESCI.
Keywords
european journal of clinical investigation, clinical investigations, clinical medicine, immunology, general medicine, metabolic disease, molecular biology, pathogenic mechanisms, pathophysiology, physiology
The European Journal of Clinical Investigation (EJCI), in publication since 1970, is a peer-reviewed general-interest biomedical journal with a broad readership. It is the official journal of the European Society for Clinical Investigation (ESCI).
Aims and Scope
EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.
Readership
Interpreting clinical investigation, the journal widely covers all aspects of this multidisciplinary field. The editorial board reflects the broad approach of the journal. The readership covers all specialities within this area of research and is predominantly read by physicians and laboratory research workers. Received by all members of ESCI.
Keywords
european journal of clinical investigation, clinical investigations, clinical medicine, immunology, general medicine, metabolic disease, molecular biology, pathogenic mechanisms, pathophysiology, physiology
No comments:
Post a Comment